Aurisco Pharmaceutical (605116.SH) passed the drug Good Manufacturing Practice (GMP) compliance inspection.
Aorui (605116.SH) announced that recently, the company received the "Drug GMP Compliance Inspection Notice" (Zhejiang 2025 No. 0267, Zhejiang 2025 No. 0268) issued by the Zhejiang Provincial Drug Administration, with inspection scope and related workshops and production lines as follows: 1. Active Pharmaceutical Ingredients (Clobetasone butyrate): 806, 863 workshops, A3 production line; 2. Active Pharmaceutical Ingredients (Betamethasone): 802 workshop, BETB production line.
Aurisco Pharmaceutical (605116.SH) announced recently that the company has received the "Drug GMP Compliance Inspection Notice" (Zhe 2025 No. 0267, Zhe 2025 No. 0268) issued by the Zhejiang Provincial Drug Administration, which includes the inspection scope and related workshops and production lines: 1. active pharmaceutical ingredient (desonide): workshops 806, 863, production line A3; 2. active pharmaceutical ingredient (betamethasone): workshop 802, production line BETB.
The company passed the drug GMP compliance inspection this time, indicating that the company's related production lines meet GMP requirements, which will be beneficial for the company to continue maintaining stable product quality and sustainable production capacity to meet market demand for related drugs. The results of this drug GMP compliance inspection will not have a significant impact on the company's performance.
Related Articles
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%
US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%
US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
